Allograft inflammatory factor 1 ELISA
Designed for the measurement of AIF-1 in human serum and plasma, the innovative AIF-1 ELISA is suitable for the determination of a novel biomarker relevant particularly to the risk of transplant rejection or vasculopathy and graft versus host disease. Allograft inflammatory factor-1 (AIF-1) is an interferon gamma-inducible cytoplasmic protein constitutively expressed in inflammatory cells and inducible in vascular smooth muscle cells in response to injury or inflammatory stimuli, including rejection or balloon angioplasty. Its expression correlates with cardiac rejection and the development of cardiac allograft vasculopathy. AIF-1 expression levels and protein concentrations were also studied in atherosclerosis, nephritis, arthritis, breast cancer and others. The BioVendor assay meets all the requirements for the routine clinical use in manual manner as well as on open ELISA robotic systems.
Supplier: BioVendor Research and Diagnostic Products
Website:
